These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 2549430)

  • 21. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
    Fujino K; Sperelakis N; Solaro RJ
    Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154.
    Abe Y; Ishisu R; Onishi K; Sekioka K; Narimatsu A; Nakano T
    J Pharmacol Exp Ther; 1996 Feb; 276(2):433-9. PubMed ID: 8632307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of saterinone and its enantiomers R(+)-saterinone and S(-)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts.
    Zimmermann W; Scholz H; Schumacher C; Wenzlaff H; Haverich A
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jun; 349(6):611-8. PubMed ID: 7526225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pimobendan on the L-type Ca2+ current and developed tension in guinea-pig ventricular myocytes and papillary muscle: comparison with IBMX, milrinone, and cilostazol.
    Matsui K; Kiyosue T; Wang JC; Dohi K; Arita M
    Cardiovasc Drugs Ther; 1999 Apr; 13(2):105-13. PubMed ID: 10372225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
    Szilágyi S; Pollesello P; Levijoki J; Haikala H; Bak I; Tósaki A; Borbély A; Edes I; Papp Z
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):369-76. PubMed ID: 16116344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase inhibition and positive inotropy in failing human myocardium.
    Schmitz W; Eschenhagen T; Mende U; Müller FU; Neumann J; Scholz H
    Basic Res Cardiol; 1992; 87 Suppl 1():65-71. PubMed ID: 1323266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UD-CG 115--a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle.
    Honerjäger P; Heiss A; Schäfer-Korting M; Schönsteiner G; Reiter M
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):259-69. PubMed ID: 6328334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
    Endoh M; Shibasaki T; Satoh H; Norota I; Ishihata A
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytes.
    Kajimoto K; Hagiwara N; Kasanuki H; Hosoda S
    Br J Pharmacol; 1997 Aug; 121(8):1549-56. PubMed ID: 9283687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of pimobendan, its active metabolite UD-CG 212, and milrinone on isolated blood vessels.
    Fujimoto S
    Eur J Pharmacol; 1994 Nov; 265(3):159-66. PubMed ID: 7875231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.
    Lues I; Beier N; Jonas R; Klockow M; Haeusler G
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of inotropic selectivity of phosphodiesterase enzyme inhibitors in-vitro.
    Smith GW; Hall JC; West PA
    J Pharm Pharmacol; 1987 Sep; 39(9):748-51. PubMed ID: 2890746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential inhibition by selective phosphodiesterase inhibitors of antigen, LTC4 and histamine-induced contraction of guinea-pig isolated trachea.
    Planquois JM; Ruffin-Morin Y; Lagente V; Payne AN; Dahl SG
    Pulm Pharmacol; 1996 Aug; 9(4):251-8. PubMed ID: 9160414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
    Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
    J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts.
    Rump AF; Acar D; Klaus W
    Br J Pharmacol; 1994 Jul; 112(3):757-62. PubMed ID: 7921599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
    Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
    Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B; Pyne NJ; Houslay MD
    Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H; Kaheinen P; Levijoki J; Lindén IB
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria.
    Muller B; Lugnier C; Stoclet JC
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):444-51. PubMed ID: 1691369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".
    Beier N; Harting J; Jonas R; Klockow M; Lues I; Haeusler G
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):17-27. PubMed ID: 1719287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.